These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 2540215

  • 1. Aldose reductase in the etiology of diabetic complications: I. Introduction.
    Harrison HE, Stribling D, Armstrong FM, Perkins CM.
    J Diabet Complications; 1989; 3(1):6-11. PubMed ID: 2540215
    [No Abstract] [Full Text] [Related]

  • 2. The identification of aldose reductase in the pathogenesis of diabetic complications: the background.
    Kador PF, Kinoshita JH.
    Diabet Med; 1985 May; 2(3):187-9. PubMed ID: 2952417
    [No Abstract] [Full Text] [Related]

  • 3. Aldose reductase in diabetic cataracts.
    Kinoshita JH, Kador P, Catiles M.
    JAMA; 1981 Jul 17; 246(3):257-61. PubMed ID: 6787220
    [No Abstract] [Full Text] [Related]

  • 4. Aldose reductase in the etiology of diabetic complications: 2. Nephropathy.
    Stribling D, Armstrong FM, Harrison HE.
    J Diabet Complications; 1989 Jul 17; 3(2):70-6. PubMed ID: 2526143
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aldose reductase inhibitors and diabetic complications.
    Raskin P, Rosenstock J.
    Am J Med; 1987 Aug 17; 83(2):298-306. PubMed ID: 3113248
    [No Abstract] [Full Text] [Related]

  • 7. Aldose reductase inhibition, glomerular metabolism, and diabetic nephropathy.
    Cohen M.
    Diabet Med; 1985 May 17; 2(3):203-6. PubMed ID: 3032499
    [No Abstract] [Full Text] [Related]

  • 8. Aldose reductase in the diabetic eye. XLIII Edward Jackson memorial lecture.
    Kinoshita JH.
    Am J Ophthalmol; 1986 Dec 15; 102(6):685-92. PubMed ID: 3098107
    [Abstract] [Full Text] [Related]

  • 9. Glutathione redox state is not the link between polyol pathway activity and myo-inositol-related Na+-K+-ATPase defect in experimental diabetic neuropathy.
    Carroll PB, Thornton BM, Greene DA.
    Diabetes; 1986 Nov 15; 35(11):1282-5. PubMed ID: 3019809
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The involvement of aldose reductase in diabetic complications.
    Kinoshita JH, Nishimura C.
    Diabetes Metab Rev; 1988 Jun 15; 4(4):323-37. PubMed ID: 3134179
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunohistochemical localization for aldose reductase in diabetic lenses.
    Akagi Y, Kador PF, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1987 Jan 15; 28(1):163-7. PubMed ID: 3100473
    [Abstract] [Full Text] [Related]

  • 14. Symposium: Aldose reductase and the complications of diabetes mellitus: reviews of preclinical studies in eyes, nerves, and kidneys. London, September 1984. Proceedings.
    Diabet Med; 1985 May 15; 2(3):185-212. PubMed ID: 2952416
    [No Abstract] [Full Text] [Related]

  • 15. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
    Greene DA, Lattimer SA.
    Am J Med; 1985 Nov 15; 79(5A):13-7. PubMed ID: 3000175
    [Abstract] [Full Text] [Related]

  • 16. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition.
    Greene DA, Mackway AM.
    Diabetes; 1986 Oct 15; 35(10):1106-8. PubMed ID: 3019804
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
    Hotta N, Sakamoto N.
    Nihon Rinsho; 1987 Dec 15; 45(12):3010-27. PubMed ID: 3128677
    [No Abstract] [Full Text] [Related]

  • 19. The pharmacology of aldose reductase inhibitors.
    Kador PF, Robison WG, Kinoshita JH.
    Annu Rev Pharmacol Toxicol; 1985 Dec 15; 25():691-714. PubMed ID: 3923907
    [No Abstract] [Full Text] [Related]

  • 20. The dog as a model for ocular manifestations of high concentrations of blood sugars.
    Wyman M, Sato S, Akagi Y, Terubayashi H, Datiles M, Kador PF.
    J Am Vet Med Assoc; 1988 Nov 01; 193(9):1153-6. PubMed ID: 3143694
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.